Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Pattern recognition receptors (PRRs) and immune effectors represent the fundamental machinery of the innate immune system. PRRs, including Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs), are specialized proteins that identify pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) [1][2]. Once these receptors are engaged, they initiate complex intracellular signaling pathways that culminate in the recruitment and activation of immune effectors, such as cytokines, chemokines, and the complement system [2]. This coordinated response is essential for the immediate defense against pathogens and the subsequent activation of adaptive immunity. However, aberrant PRR signaling or effector production is a hallmark of various pathologies, including sepsis, chronic inflammatory diseases, and cancer [3]. Therapeutic strategies often target specific members of this group, using agonists to boost immunity in oncology or vaccine development, and antagonists to dampen pathological inflammation in autoimmune conditions [3].
Modulation of innate immune signaling through the activation or inhibition of specific pattern recognition receptors or their downstream signaling effectors to regulate inflammatory and adaptive immune responses.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pattern recognition receptors and immune effectors (PRRs).